News & Events

As the EU Falsified Medicines Directive (FMD) enforcement date draws closer, companies across the pharmaceutical industry are working hard to overcome implementation hurdles.

With just a couple of months until the EU Falsified Medicines Directive (FMD) comes into force, companies who have left it too late to implement their own serialization solution are now relying on support from third party providers, whose...

Over the last year there has been a lot of discussion surrounding the use of digitization, automation and artificial intelligence (AI) in the pharmaceutical industry. And, as we move into 2019 this is likely to continue.

As 2018 draws to a close, the industry is starting to consider what 2019 will bring. As new technologies emerge, and pharmaceutical companies start to think about how they could be applied to their operations, there is an increasing focus on...

Counterfeit medicines pose a huge threat to patient safety, which has been the primary driver behind new global serialization regulations, such as the US Drug Supply Chain Safety Act (DSCSA) and the EU Falsified Medicines Directive (FMD).

Tjoapack has been marked a vital business by the Dutch government (production and transportation of medicines). As such, Tjoapack has taken the following preventive measures to protect employees, visitors, contractors, and others in and around the...

Tjoapack Netherlands B.V., a global contract packaging organisation (CPO) for the pharmaceutical industry, today announced a majority investment from Ampersand Capital Partners, a private equity firm that specializes in partnering with...

Global contract packaging organisation (CPO), Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials.